Albumin at the start of peritoneal dialysis predicts the development of peritonitis

American Journal of Kidney Diseases

Volumn 41, Issue 3, 2003, Pages 664-669

  Wang, Qin ^b   Bernardini, Judith ^b   Piraino, Beth ^b   Fried, Linda ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Albumin; Hypoalbuminemia; Incidence; Peritoneal dialysis (PD); Peritonitis

Indexed keywords

ALBUMIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; DIABETES MELLITUS; FEMALE; HUMAN; HYPOALBUMINEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PERITONEAL DIALYSIS; PERITONITIS;

EID: 0037374467     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2003.50128     Document Type: Article

References (17)

1. Piraino B, Bernardini J, Sorkin M: The influence of peritoneal catheter exit-site infections on peritonitis, tunnel infections, and catheter loss in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 8:436-440, 1986
2. Holley J, Bernadini J, Piraino B: Catheter infections in insulin-dependent diabetics on continuous ambulatory peritoneal dialysis. Perit Dial Int 11:347-350, 1990
3. Oxton LL, Zimmerman SW, Roecker EB, et al: Risk factors for peritoneal dialysis-related infections. Perit Dial Int 14:137-144, 1993
4. Sharma AP, Gupta A, Sharma RK, et al: Does serum albumin at start of continuous ambulatory peritoneal dialysis or its drop during continuous ambulatory peritoneal dialysis determine patient outcome? Adv Perit Dial 16:119-122, 2000
5. Fox L, Tzamaloukas AH, Murata GH: Metabolic differences between persistent and routine peritonitis in continuous ambulatory peritoneal dialysis. Adv Perit Dial 8:346-350, 1992
6. Charlson ME, Pompei P, Ales KL: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383, 1987
7. Fried L, Bernardini J, Piraino B: Charlson Comorbidity Index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis 37:337-342, 2001
8. Miskulin DC, Athienites NV, Yan G, et al for the Hemodialysis (HEMO) Study Group: Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial. Kidney Int 60:1498-1510, 2001
9. Churchill DN, Taylor DW, Cook RJ, et al: Canadian hemodialysis morbidity study. Am J Kidney Dis 19:214-234, 1992
10. Powe NR, Jaar B, Furth SL, et al: Septicemia in dialysis patients: Incidence, risk factors, and prognosis. Kidney Int 55:1081-1090, 1999
11. Peters T: All About Albumin: Biochemistry, Genetics, and Medical Applications. San Diego, CA, Academic, 1996
12. Peters T: Serum albumin. Adv Protein Chem 37:161-245, 1985
13. Emerson TE: Unique feature of albumin: A brief review. Crit Care Med 17:690-694, 1989
14. Iglesias J, Abernethy E, Wang Z, et al: Albumin is a major serum survival factor for renal tubular cells and macrophages through scavenging of ROS. Am J Physiol 277:F711-F722, 1999
15. Gomez-Munoz A, O'Brien L, Hundal R, et al: Lysophosphatidylcholine stimulates phospholipase D activity in mouse peritoneal macrophages. J Lipid Res 40:988-993, 1990
16. Kaysen G: The microinflammatory state in uremia: Causes and potential consequences. J Am Soc Nephrol 12:1549-1557, 2001
17. Cueto-Manzano AM, Gamba G, Correa-Rotter R: Quantification and characterization of protein loss in continuous ambulatory peritoneal dialysis. Rev Invest Clin 52:611-617, 2000